Our findings with administration of t-TUCB are similar to those from a previous study where OVA-challenged mice administered with t-TUCB demonstrated increased levels of EETs (5,6-, 11,12-, and 14, 15-) associated with decreased eosinophilia and reduced IL-4 and IL-5 levels (Yang et al., 2015). This evidence concerns the gene IL4 and Increased total eosinophil count.